This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05059444
Recruitment Status : Recruiting
First Posted : September 28, 2021
Last Update Posted : September 9, 2022
Sponsor:
Information provided by (Responsible Party):
Guardant Health, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2028
Estimated Study Completion Date : February 2028